LIR Life Sciences Corp. (CSE:SKNY)

Canada flag Canada · Delayed Price · Currency is CAD
1.620
+0.070 (4.52%)
Dec 11, 2025, 1:13 PM EST
Market Cap29.37M
Revenue (ttm)n/a
Net Income (ttm)-412.50K
Shares Out18.95M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,100
Average Volume86,564
Open1.610
Previous Close1.550
Day's Range1.550 - 1.630
52-Week Range0.450 - 2.000
Betan/a
RSI65.82
Earnings Daten/a

About LIR Life Sciences

LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada. [Read more]

Industry Pharmaceutical Preparations
Founded 2024
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol SKNY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.